Attributes | Values |
---|
rdf:type
| |
Description
| - To ascertain the involvement of 5-HT2 receptor subtype in rewarding properties of methamphetamine (METH), non-selective 5-HT2 agonist alpha-methyl-5-hydroxytryptamine was tested for its ability to influence METH "i.v. self-administration" in rats. From our results, 5-HT2 receptor activation slightly attenuated METH self-administration. This ability can be hypothetically mediated via supression of either "craving" or sensitization mechanisms.
- To ascertain the involvement of 5-HT2 receptor subtype in rewarding properties of methamphetamine (METH), non-selective 5-HT2 agonist alpha-methyl-5-hydroxytryptamine was tested for its ability to influence METH "i.v. self-administration" in rats. From our results, 5-HT2 receptor activation slightly attenuated METH self-administration. This ability can be hypothetically mediated via supression of either "craving" or sensitization mechanisms. (en)
- To ascertain the involvement of 5-HT2 receptor subtype in rewarding properties of methamphetamine (METH), non-selective 5-HT2 agonist alpha-methyl-5-hydroxytryptamine was tested for its ability to influence METH "i.v. self-administration" in rats. From our results, 5-HT2 receptor activation slightly attenuated METH self-administration. This ability can be hypothetically mediated via supression of either "craving" or sensitization mechanisms. (cs)
|
Title
| - Pretreatment with alpha-methyl-5-hydroxytryptamine attenuates methamphetamine i.v. self-administration in rats
- Pretreatment with alpha-methyl-5-hydroxytryptamine attenuates methamphetamine i.v. self-administration in rats (en)
- Pretreatment with alpha-methyl-5-hydroxytryptamine attenuates methamphetamine i.v. self-administration in rats (cs)
|
skos:prefLabel
| - Pretreatment with alpha-methyl-5-hydroxytryptamine attenuates methamphetamine i.v. self-administration in rats
- Pretreatment with alpha-methyl-5-hydroxytryptamine attenuates methamphetamine i.v. self-administration in rats (en)
- Pretreatment with alpha-methyl-5-hydroxytryptamine attenuates methamphetamine i.v. self-administration in rats (cs)
|
skos:notation
| - RIV/00216224:14110/03:00008734!RIV08-MSM-14110___
|
http://linked.open.../vavai/riv/strany
| |
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/00216224:14110/03:00008734
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - 5-HT2 receptor subtype; methamphetamine; %22i.v. self-administration%22; rats (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...v/mistoKonaniAkce
| - April 5 - 10, 2003, Sölden (Ötztal), Rakousko
|
http://linked.open...i/riv/mistoVydani
| - Sölden (Ötztal), Rakousko
|
http://linked.open...i/riv/nazevZdroje
| - PROGRAMME AND ABSTRACTS of 5th NEUROCHEMISTRY WINTER CONFERENCE
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...iv/tvurceVysledku
| |
http://linked.open...vavai/riv/typAkce
| |
http://linked.open.../riv/zahajeniAkce
| |
http://linked.open...n/vavai/riv/zamer
| |
number of pages
| |
http://purl.org/ne...btex#hasPublisher
| |
http://localhost/t...ganizacniJednotka
| |